95 related articles for article (PubMed ID: 23927387)
1. Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial.
Herman MC; van den Brink MJ; Geomini PM; van Meurs HS; Huirne JA; Eising HP; Timmermans A; Pijnenborg JM; Klinkert ER; Coppus SF; Nieboer TE; Catshoek R; van der Voet LF; van Eijndhoven HW; Graziosi GC; Veersema S; van Kesteren PJ; Langenveld J; Smeets NA; van Vliet HA; van der Steeg JW; Lisman-van Leeuwen Y; Dekker JH; Mol BW; Berger MY; Bongers MY
BMC Womens Health; 2013 Aug; 13():32. PubMed ID: 23927387
[TBL] [Abstract][Full Text] [Related]
2. A 52-mg levonorgestrel-releasing intrauterine system vs bipolar radiofrequency nonresectoscopic endometrial ablation in women with heavy menstrual bleeding: long-term follow-up of a multicenter randomized controlled trial.
Huijs DPC; Derickx AJM; Beelen P; Leemans JC; van Kuijk SMJ; Bongers MY; Geomini PMAJ
Am J Obstet Gynecol; 2024 May; 230(5):542.e1-542.e10. PubMed ID: 38280433
[TBL] [Abstract][Full Text] [Related]
3. Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients.
Middleton LJ; Champaneria R; Daniels JP; Bhattacharya S; Cooper KG; Hilken NH; O'Donovan P; Gannon M; Gray R; Khan KS; ; Abbott J; Barrington J; Bhattacharya S; Bongers MY; Brun JL; Busfield R; Sowter M; Clark TJ; Cooper J; Cooper KG; Corson SL; Dickersin K; Dwyer N; Gannon M; Hawe J; Hurskainen R; Meyer WR; O'Connor H; Pinion S; Sambrook AM; Tam WH; van Zon-Rabelink IA; Zupi E
BMJ; 2010 Aug; 341():c3929. PubMed ID: 20713583
[TBL] [Abstract][Full Text] [Related]
4. Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding.
Hoaglin DC; Filonenko A; Glickman ME; Wasiak R; Gidwani R
Eur J Med Res; 2013 Jun; 18(1):17. PubMed ID: 23786677
[TBL] [Abstract][Full Text] [Related]
5. Thirty years of mirena: A story of innovation and change in women's healthcare.
Gemzell-Danielsson K; Kubba A; Caetano C; Faustmann T; Lukkari-Lax E; Heikinheimo O
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):614-618. PubMed ID: 33544887
[TBL] [Abstract][Full Text] [Related]
6. Essure microinsert hysteroscopic tubal sterilization: eight-years follow-up results.
Sakinci M; Aksu T; Kuru O; Ozekinci M; Sanhal C
Clin Exp Obstet Gynecol; 2015; 42(1):72-8. PubMed ID: 25864287
[TBL] [Abstract][Full Text] [Related]
7. Use of the levonorgestrel intrauterine system in postmenopause.
Al-Azzawi F
Climacteric; 2015 Jun; 18(3):431-2. PubMed ID: 25966862
[No Abstract] [Full Text] [Related]
8. Hysteroscopic Essure Inserts for Permanent Contraception: Extended Follow-Up Results of a Phase III Multicenter International Study.
Chudnoff SG; Nichols JE; Levie M
J Minim Invasive Gynecol; 2015; 22(6):951-60. PubMed ID: 25917278
[TBL] [Abstract][Full Text] [Related]
9. Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
Heikinheimo O; Inki P; Schmelter T; Gemzell-Danielsson K
Hum Reprod; 2014 Jun; 29(6):1182-8. PubMed ID: 24682613
[TBL] [Abstract][Full Text] [Related]
10. Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one-year randomised controlled trial.
Mawet M; Nollevaux F; Nizet D; Wijzen F; Gordenne V; Tasev N; Segedi D; Marinescu B; Enache A; Parhomenko V; Frankenne F; Foidart JM
Eur J Contracept Reprod Health Care; 2014 Jun; 19(3):169-79. PubMed ID: 24666176
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal hormone therapy-also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma.
Koskela-Niska V; Pukkala E; Lyytinen H; Ylikorkala O; Dyba T
Int J Cancer; 2015 Oct; 137(8):1947-52. PubMed ID: 25846583
[TBL] [Abstract][Full Text] [Related]
12. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review.
Birgisson NE; Zhao Q; Secura GM; Madden T; Peipert JF
J Womens Health (Larchmt); 2015 May; 24(5):349-53. PubMed ID: 25825986
[TBL] [Abstract][Full Text] [Related]
13. Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration.
McNicholas C; Maddipati R; Zhao Q; Swor E; Peipert JF
Obstet Gynecol; 2015 Mar; 125(3):599-604. PubMed ID: 25730221
[TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
Beelen P; van den Brink MJ; Herman MC; Geomini PMAJ; Dekker JH; Duijnhoven RG; Mak N; van Meurs HS; Coppus SF; van der Steeg JW; Eising HP; Massop-Helmink DS; Klinkert ER; Nieboer TE; Timmermans A; van der Voet LF; Veersema S; Smeets NAC; Schutte JM; van Baal M; Bossuyt PM; Mol BWJ; Berger MY; Bongers MY
Am J Obstet Gynecol; 2021 Feb; 224(2):187.e1-187.e10. PubMed ID: 32795428
[TBL] [Abstract][Full Text] [Related]
15. Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(18):1-119. PubMed ID: 27990196
[TBL] [Abstract][Full Text] [Related]
16. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
Bergeron C; Laberge PY; Boutin A; Thériault MA; Valcourt F; Lemyre M; Maheux-Lacroix S
Hum Reprod Update; 2020 Feb; 26(2):302-311. PubMed ID: 31990359
[TBL] [Abstract][Full Text] [Related]
17. First and second-generation endometrial ablation devices: A network meta-analysis.
Marchand GJ; Masoud A; Grover S; King A; Brazil G; Ulibarri H; Parise J; Arroyo A; Coriell C; Moir C; Govindan M
BMJ Open; 2024 May; 14(5):e065966. PubMed ID: 38806429
[TBL] [Abstract][Full Text] [Related]
18. Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis.
Bofill Rodriguez M; Dias S; Jordan V; Lethaby A; Lensen SF; Wise MR; Wilkinson J; Brown J; Farquhar C
Cochrane Database Syst Rev; 2022 May; 5(5):CD013180. PubMed ID: 35638592
[TBL] [Abstract][Full Text] [Related]
19. The levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding: a cost-effectiveness analysis.
van den Brink MJ; Beelen P; Herman MC; Geomini PM; Dekker JH; Vermeulen KM; Bongers MY; Berger MY
BJOG; 2021 Nov; 128(12):2003-2011. PubMed ID: 34245652
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
